�鶹��Ƶ

Paul, Weiss’s life sciences and healthcare practice integrates deep knowledge of the industry with unparalleled transactional, antitrust, litigation, regulatory and patent dispute capabilities. Our broad experience enables us to quickly identify and proactively address the most complex issues arising in connection with a potential transaction, dispute or enforcement action. We understand the continually shifting regulations and fast-moving market opportunities impacting life sciences and healthcare companies; whether in transactional or litigation context, our focus is on ensuring that our clients’ core patented technologies and R&D assets are protected and strengthened.

Our clients range from leading and next-generation pharmaceutical, biotechnology and medical device pioneers, to innovative healthcare companies and contract research organizations, to the most active investors in the industry.

Mergers and Acquisitions

We have decades of experience working hand in hand with life science companies of all sizes on their most complex M&A, investments and other business ventures, including novel deal structures. We leverage formidable capabilities, including an experienced deal-focused IP team and top-tier capital markets, finance, tax, executive compensation and corporate governance practices.

Antitrust

We advise life science clients on transactions and regulatory clearance; advocate before regulators; and handle antitrust litigation, counseling and investigations. With a deep bench of former DOJ, FTC and European Commission officials, our team successfully handles matters involving significant reputational and financial exposure. Our advisory work for clients often begins in the boardroom, where we provide counsel on mitigating antitrust risk.

Litigation

Recognized as having the nation’s preeminent litigation and regulatory practice, Paul, Weiss has helped numerous life science businesses and boards mitigate and safely resolve “bet-the-company” securities and other litigation crises, winning trials, prevailing on motions or negotiating favorable resolutions. We also have a preeminent team of merger disputes experts with a track record of fending off attempts to block or enforce a deal, often breaking new legal ground in the process.

White Collar & Regulatory Defense

Anchored by numerous former federal prosecutors from virtually every major regulatory agency, we regularly defend leading life science corporations and their executives in fraud enforcement investigations initiated by DOJ and state attorneys general as well as in related False Claims Act, Anti-Kickback and qui tam litigations; internal investigations and compliance reviews; and other matters.

Patent Disputes

Our life science-focused patent group is among the U.S.’s most formidable trial teams, regularly appearing before the district courts, Federal Circuit, U.S. Patent and Trademark Office, U.S. International Trade Commission and Supreme Court. Our team leverages a thorough understanding of and passion for science and technology to explain the patents at issue to judges and juries, whether they involve biotechnology, molecular biology, small molecule chemistry, immunology, analytic and organic chemistry, computer engineering, electrical engineering and mechanical engineering.